Compare AEMD & TWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AEMD | TWAV |
|---|---|---|
| Founded | 1984 | N/A |
| Country | United States | United States |
| Employees | N/A | 130 |
| Industry | Medical/Dental Instruments | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3M | 5.1M |
| IPO Year | 2008 | 2000 |
| Metric | AEMD | TWAV |
|---|---|---|
| Price | $5.86 | $1.49 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $13.25 | N/A |
| AVG Volume (30 Days) | ★ 2.4M | 75.6K |
| Earning Date | 11-11-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 90.77 |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $2,437,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.38 |
| Revenue Growth | N/A | ★ 2.48 |
| 52 Week Low | $0.53 | $0.58 |
| 52 Week High | $35.97 | $2.58 |
| Indicator | AEMD | TWAV |
|---|---|---|
| Relative Strength Index (RSI) | 58.98 | 50.13 |
| Support Level | $3.20 | $1.17 |
| Resistance Level | $6.69 | $1.86 |
| Average True Range (ATR) | 0.34 | 0.16 |
| MACD | -0.14 | -0.02 |
| Stochastic Oscillator | 0.89 | 21.28 |
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
TaoWeave Inc is a digital asset company. The company offers investors a regulated, publicly traded vehicle to gain exposure to the decentralized AI economy. The company aims to invest in the Bittensor ecosystem through partnerships with subnets, miners, and validators, and operates with zero debt by maintain appropriate cash reserves. The Company currently operates in three segments: (1) "Digital Assets", which represents the business surrounding treasury activity with Bittensor, (2) Collaboration Products which represents the business surrounding Mezzanine product offerings, and (3) Managed Services, which represents the business surrounding managed services for video collaboration and network solutions.